Expert Review of Precision Medicine and Drug Development

Tackling pharmacological response heterogeneity by PBPK modeling to advance precision medicine productivity of nanotechnology and genomics therapeutics

Impact of NCI-MATCH: a Nationwide Oncology Precision Medicine Trial

Emerging DNA methylation inhibitors for cancer therapy: challenges and prospects

Dissecting the molecular landscape of pancreatic cancer: towards a precision medicine approach

Precision therapy in advanced urothelial cancer

Precision medicine in multiple myeloma: are we there yet?

Using organoid models to predict chemotherapy efficacy: the future of precision oncology?

Privacy and ethical challenges in next-generation sequencing

The treatment of multiple myeloma in an era of precision medicine

Precision medicine for the treatment of sepsis: recent advances and future prospects

Leaving some behind: the growing gap in precision medicine for minority populations

Precision medicine for TP53-mutated acute myeloid leukemia

An analysis of available biomarker data for targeting cyclin-dependent kinases 4 and 6 (CDK4/6) in breast cancer

Personalized therapies for the treatment of allergic rhinitis

Cardiac imaging and circulating biomarkers for primary prevention in the era of precision medicine

Development and implementation of precision therapies targeting base-excision DNA repair in BRCA1-associated tumors

Novel therapeutic targets and drug development for the precision treatment of COPD

Advances in precision epigenetic treatment for acute promyelocytic leukemia.

Human regulatory T cells (Treg) and their response to cancer

Sickle cell disease in the era of precision medicine: looking to the future

New strategies for the precision treatment of HER2-driven tumours

Using metabolomics to develop precision medicine strategies to treat nonalcoholic steatohepatitis

How does race and ethnicity effect the precision treatment of asthma?

Lessons learned from exceptional responders

Personalized approach to systemic therapy of renal cancer

A ‘sandwich’ strategy promises functional cure of chronic hepatitis B

Precision medicine for pediatric central nervous system tumors

DNA damage response as biomarkers informing a precision medicine approach to bladder cancer: what are the next steps?

Gilteritinib for the treatment of patients with FLT3 mutated relapsed or refractory acute myeloid leukemia

Gene therapy trials for haemophilia: a step closer to a cure?

Recent advances towards gene therapy for propionic acidemia: translation to the clinic

New treatment targets in multiple sclerosis therapy

How clinical biobanks can support precision medicine: from standardized preprocessing to treatment guidance